Nila Rafiq

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver

Nila Rafiq, Chunhong Bai, Yun Fang et al. · Clinical Gastroenterology and Hepatology · 2008 · 733 citations

Obesity, Metabolic Associated Steatohepatitis, Hepatology +7

Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality

Zobair M. Younossi, Maria Stepanova, Nila Rafiq et al. · Hepatology · 2011 · 621 citations

Epidemiology of chronic liver diseases in the USA in the past three decades

Zobair M. Younossi, Maria Stepanova, Youssef Younossi et al. · Gut · 2019 · 535 citations

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9